
iTeos Therapeutics ITOS
Quartalsbericht 2025-Q2
hinzugefügt 06.08.2025
iTeos Therapeutics P/S 2011-2026 | ITOS
P/S Jährlich iTeos Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.37 | 33.4 | 2.07 | 4.75 | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 33.4 | 2.07 | 12.2 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Grifols, S.A.
GRFS
|
1.71 | $ 8.24 | -0.12 % | $ 6.83 B | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 229.25 | 0.44 % | $ 5 B | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
AbbVie
ABBV
|
24.1 | $ 208.84 | -2.86 % | $ 369 B | ||
|
AbCellera Biologics
ABCL
|
12.8 | $ 3.52 | 0.28 % | $ 1.05 B | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | ||
|
Agenus
AGEN
|
0.857 | $ 3.33 | -2.06 % | $ 99 M | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
8.96 | $ 14.81 | 2.63 % | $ 2.25 B | ||
|
Altimmune
ALT
|
7.76 K | $ 3.34 | 7.05 % | $ 294 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 91.18 | 1.97 % | $ 27.2 B | ||
|
Amgen
AMGN
|
5.4 | $ 347.94 | -1.51 % | $ 187 B | ||
|
ANI Pharmaceuticals
ANIP
|
1.95 | $ 74.21 | -2.3 % | $ 1.43 B | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
2.65 | $ 8.03 | 2.29 % | $ 220 M | ||
|
Aurinia Pharmaceuticals
AUPH
|
24.1 | $ 15.61 | 0.9 % | $ 2.1 B | ||
|
Autolus Therapeutics plc
AUTL
|
4.27 | $ 1.41 | 2.17 % | $ 375 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.68 | 1.52 % | $ 16.8 M | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
AstraZeneca PLC
AZN
|
2.17 | - | - | $ 96.9 B | ||
|
Burford Capital Limited
BUR
|
6.35 | $ 4.14 | -2.59 % | $ 683 M | ||
|
Atea Pharmaceuticals
AVIR
|
2.11 | $ 5.76 | 1.95 % | $ 469 M | ||
|
BioCryst Pharmaceuticals
BCRX
|
3.81 | $ 9.02 | -3.84 % | $ 1.86 B | ||
|
Axon Enterprise
AXON
|
19.1 | $ 412.81 | -2.54 % | $ 31.3 B | ||
|
Alnylam Pharmaceuticals
ALNY
|
11 | $ 318.85 | -3.01 % | $ 41.8 B | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M |